Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Wilby, J., Kainth, A, Hawkins, N, Epstein, D, McIntosh, H, McDaid, C, Mason, A, Golder, S, O'Meara, S, Sculpher, M, & others Health Technology Assessment, 2005.
bibtex   
@article{wilby_clinical_2005-1,
	title = {Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation},
	journal = {Health Technology Assessment},
	author = {Wilby, Jennifer and Kainth, A and Hawkins, N and Epstein, D and McIntosh, H and McDaid, C and Mason, A and Golder, S and O'Meara, S and Sculpher, M and {others}},
	year = {2005},
	keywords = {Adolescent, Adult, Anticonvulsants, Clinical Trials as Topic, Cost-Benefit Analysis, Epilepsy, Female, Humans, Male, Randomized Controlled Trials as Topic, Treatment Outcome, United Kingdom},
}

Downloads: 0